← Open Payments lookup

IBRAHIM DAGHER: Open Payments

NPI 1992238745 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,404 in 207 payments from 13 companies in 2025. Trend: 2023 $412 · 2024 $1,404 · 2025 $3,404

Food & beverage: $3,143Honoraria: $150Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.59$763
E.R. Squibb & Sons, L.L.C.31$523
Alkermes, Inc.29$483
Teva Pharmaceuticals USA, Inc.13$340
Neurocrine BioSciences, Inc.21$321
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$217
Janssen Pharmaceuticals, Inc11$187
ABBVIE INC.12$184
H2-Pharma, LLC1$150
Axsome Therapeutics, Inc.6$105

Products named: COBENFY, REXULTI, ARISTADA, ABILIFY MAINTENA, INGREZZA, CAPLYTA, UZEDY, INVEGA SUSTENNA.

Industry payments across CA — which companies pay providers there.